Research graph
References from Clinical profile, guideline-directed therapy uptake, and in-hospital mortality in acute heart failure at a public teaching hospital in southwestern Colombia: a single-centre retrospective registry (EVARISTO-AHF). Local targets link to admitted publications; unresolved targets remain external evidence.
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
10.1093/eurheartj/ehab368 · 2021 · External reference
Global burden of heart failure: a comprehensive and updated review of epidemiology
10.1093/cvr/cvac013 · 2022 · External reference
Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003
10.1161/circulationaha.108.812172 · 2009 · External reference
Understanding the epidemic of heart failure: past, present, and future
10.1007/s11897-014-0220-x · 2014 · External reference
European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions
10.1002/ejhf.566 · 2016 · External reference
EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients
10.1093/eurheartj/ehl193 · 2006 · External reference
Colombian Heart Failure Registry (RECOLFACA): results
2021 · External reference
American Registry of Ambulatory or Acutely Decompensated Heart Failure (AMERICCAASS Registry): first 1000 patients
10.1002/clc.24182 · 2024 · External reference
Decompensated heart failure in a single center of a Latin American country: findings from the first 1595 cases in the ICARUS registry
2024 · External reference
Burden of heart failure in Latin America: a systematic review and meta-analysis
2016 · External reference
The reality of heart failure in Latin America
10.1016/j.jacc.2013.06.013 · 2013 · External reference
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
10.1093/eurheartj/ehad195 · 2023 · External reference
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
2022 · External reference
Empagliflozin in heart failure with a preserved ejection fraction
10.1056/nejmoa2107038 · 2021 · External reference
Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction
10.1056/nejmoa2206286 · 2022 · External reference
Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure
10.1016/s0735-1097(03)00309-7 · 2003 · External reference
Comorbidity in heart failure: results of the Spanish RICA Registry
10.1093/qjmed/hcu127 · 2014 · External reference
Epidemiology of heart failure with preserved ejection fraction
10.1038/nrcardio.2017.65 · 2017 · External reference
Dapagliflozin in patients with heart failure and reduced ejection fraction
10.1056/nejmoa1911303 · 2019 · External reference
Cardiovascular and renal outcomes with empagliflozin in heart failure
10.1056/nejmoa2022190 · 2020 · External reference
The STROBE Statement: guidelines for reporting observational studies
10.1016/j.ijsu.2014.07.013 · 2014 · External reference
Unresolved reference
1993 · External reference
